VKA Therapy Beats Switch to NOAC in Frail AF Patients VKA Therapy Beats Switch to NOAC in Frail AF Patients

Frail patients with atrial fibrillation who were switched to a newer NOAC agent had more bleeding than those left on older vitamin K antagonists, without any benefit in terms of thromboembolic events.Medscape Medical News
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Cardiology News Source Type: news